The 2017 ACC AHA High Blood Pressure Guidelines and the US Preventive Services Task Force recommend the use of 24-hour ambulatory blood pressure monitoring, ABPM, to guide the diagnosis and management of hypertension. Several studies have reported access to ABPM services as a major barrier for patients and physicians. Furthermore, data suggests physicians are highly interested in ABPM services and patients also speak favorably of out-of-office BP measurements. Our objectives are to pilot a community pharmacy driven 24-hour ambulatory blood pressure monitoring service, develop a business model through which pharmacists are reimbursed for the service to ensure sustainability and reproducibility, and explore patient, pharmacist, and physician perceptions of and satisfaction with the service.